138.04
price up icon0.01%   0.02
after-market 시간 외 거래: 138.00 -0.04 -0.03%
loading
전일 마감가:
$138.02
열려 있는:
$137.41
하루 거래량:
898.23K
Relative Volume:
0.98
시가총액:
$13.69B
수익:
$2.41B
순이익/손실:
$305.80M
주가수익비율:
46.79
EPS:
2.95
순현금흐름:
$492.20M
1주 성능:
-3.92%
1개월 성능:
-1.67%
6개월 성능:
+28.18%
1년 성능:
+11.03%
1일 변동 폭
Value
$136.51
$140.19
1주일 범위
Value
$133.61
$149.98
52주 변동 폭
Value
$84.23
$154.61

뉴로크린 바이오사이언시스 Stock (NBIX) Company Profile

Name
명칭
Neurocrine Biosciences Inc
Name
전화
(858) 617-7600
Name
주소
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA
Name
직원
1,800
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
NBIX's Discussions on Twitter

NBIX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
138.04 13.76B 2.41B 305.80M 492.20M 2.95
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.10 63.79B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.23 43.49B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.18 40.30B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 23.21B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
453.53 20.59B 3.08B 1.24B 1.07B 25.61

뉴로크린 바이오사이언시스 Stock (NBIX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-21 개시 Citigroup Buy
2025-07-21 개시 Truist Buy
2025-07-10 개시 Goldman Buy
2025-04-15 업그레이드 Needham Hold → Buy
2025-04-14 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2025-02-11 개시 Deutsche Bank Hold
2024-10-10 재개 Raymond James Outperform
2024-08-29 업그레이드 Piper Sandler Neutral → Overweight
2024-04-24 업그레이드 Wells Fargo Equal Weight → Overweight
2023-12-13 재개 Citigroup Neutral
2023-12-12 개시 Deutsche Bank Buy
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-08-21 재확인 Mizuho Neutral
2023-07-24 업그레이드 SVB Securities Market Perform → Outperform
2023-07-06 업그레이드 BMO Capital Markets Underperform → Market Perform
2023-05-04 업그레이드 Guggenheim Neutral → Buy
2023-03-30 업그레이드 Canaccord Genuity Hold → Buy
2023-03-03 업그레이드 Evercore ISI In-line → Outperform
2023-02-03 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-11-14 다운그레이드 Evercore ISI Outperform → In-line
2022-10-11 개시 UBS Buy
2022-09-26 개시 Wells Fargo Equal Weight
2022-06-06 재개 Jefferies Buy
2022-03-03 다운그레이드 Piper Sandler Overweight → Neutral
2022-02-25 업그레이드 Goldman Neutral → Buy
2022-01-18 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-11-19 개시 BMO Capital Markets Underperform
2021-11-17 업그레이드 JP Morgan Neutral → Overweight
2021-10-14 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-09-23 재개 Needham Hold
2021-08-06 다운그레이드 Canaccord Genuity Buy → Hold
2021-05-18 재개 Goldman Neutral
2021-05-06 업그레이드 Barclays Equal Weight → Overweight
2021-02-02 개시 Raymond James Outperform
2020-09-30 개시 The Benchmark Company Hold
2020-08-04 다운그레이드 JP Morgan Overweight → Neutral
2020-06-29 다운그레이드 Goldman Buy → Neutral
2020-06-09 개시 Wedbush Outperform
2020-03-06 개시 Citigroup Buy
2020-02-27 개시 Barclays Equal Weight
2020-02-24 개시 William Blair Outperform
2020-02-06 개시 Mizuho Neutral
2020-02-05 재확인 H.C. Wainwright Buy
2019-12-13 다운그레이드 Credit Suisse Outperform → Neutral
2019-08-07 개시 RBC Capital Mkts Outperform
2019-07-16 개시 Oppenheimer Outperform
2019-06-05 개시 Guggenheim Neutral
2019-05-21 개시 Credit Suisse Outperform
2019-04-22 업그레이드 JP Morgan Neutral → Overweight
2019-04-12 개시 Evercore ISI Outperform
2019-02-06 재확인 BofA/Merrill Buy
2019-01-23 다운그레이드 JP Morgan Overweight → Neutral
2018-12-13 개시 Goldman Buy
2018-11-21 개시 Canaccord Genuity Buy
모두보기

뉴로크린 바이오사이언시스 주식(NBIX)의 최신 뉴스

pulisher
12:40 PM

Neurocrine Biosciences (NASDAQ:NBIX) Shares Gap DownWhat's Next? - MarketBeat

12:40 PM
pulisher
09:43 AM

Piper Sandler Forecasts Strong Price Appreciation for Neurocrine Biosciences (NASDAQ:NBIX) Stock - MarketBeat

09:43 AM
pulisher
08:43 AM

Needham & Company LLC Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price - MarketBeat

08:43 AM
pulisher
08:16 AM

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2025 Earnings Call Transcript - Insider Monkey

08:16 AM
pulisher
07:51 AM

What data driven models say about Neurocrine Biosciences Inc.’s futureJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com

07:51 AM
pulisher
07:44 AM

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyTrade Analysis Report & Weekly High Return Stock Forecasts - newser.com

07:44 AM
pulisher
07:32 AM

How to build a dashboard for Neurocrine Biosciences Inc. stockPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com

07:32 AM
pulisher
07:28 AM

Applying sector rotation models to Neurocrine Biosciences Inc.2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com

07:28 AM
pulisher
06:14 AM

Neurocrine Biosciences (NBIX): Net Margin Miss Challenges Bullish Earnings Growth Narratives - Yahoo Finance

06:14 AM
pulisher
05:44 AM

Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com

05:44 AM
pulisher
05:11 AM

Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 8,500 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

05:11 AM
pulisher
05:11 AM

Neurocrine Biosciences, Inc. $NBIX Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat

05:11 AM
pulisher
03:31 AM

Short interest data insights for Neurocrine Biosciences Inc.July 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com

03:31 AM
pulisher
02:53 AM

What moving averages say about Neurocrine Biosciences Inc.Market Activity Report & Consistent Profit Trading Strategies - newser.com

02:53 AM
pulisher
02:49 AM

Is it time to cut losses on Neurocrine Biosciences Inc.Earnings Recap Summary & Fast Entry High Yield Stock Tips - newser.com

02:49 AM
pulisher
Oct 29, 2025

Can Neurocrine Biosciences Inc. stock sustain revenue growthJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Neurocrine Biosciences Inc. (NB3) stock vulnerable to rate hikesQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Now the Right Time to Reassess Neurocrine Biosciences After Expansion News and Valuation Gaps? - simplywall.st

Oct 29, 2025
pulisher
Oct 29, 2025

Neurocrine Biosciences (NBIX): Evaluating Valuation After Q3 Earnings Beat and Pipeline Progress - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Neurocrine Biosciences (NASDAQ:NBIX) Issues Earnings Results - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Wedbush Raises Price Target on Neurocrine Biosciences to $149 From $143, Keeps Outperform Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Deutsche Bank Adjusts Neurocrine Biosciences Price Target to $142 From $140, Maintains Hold Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Needham Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Morgan Stanley Raises Price Target on Neurocrine Biosciences to $178 From $168, Keeps Overweight Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Sumitomo Mitsui Trust Group Inc. Buys 4,030 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences Q3 2025 Earnings Call Transcript - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences (NBIX) Q3 Earnings and Revenues Top Estimates - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

What earnings revisions data tells us about Neurocrine Biosciences Inc.Quarterly Profit Report & Daily Market Momentum Tracking - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine: Q3 Earnings Snapshot - Stamford Advocate

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences Beats Estimates But Wall Street Punishes The Stock - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Here's What Key Metrics Tell Us About Neurocrine (NBIX) Q3 Earnings - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences Tops Q3 Estimates With Growing Sales - Finimize

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences Q3 Adjusted Earnings, Revenue Rise - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences reports 28% jump in Q3 net sales, EPS beats estimates - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Flash (NBIX) Neurocrine Biosciences, Inc. Reports Q3 Revenue $794.9M, vs. FactSet Est of $746.8M - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Flash (NBIX) Neurocrine Biosciences, Inc. Posts Q3 Adjusted EPS $2.17 per Share, vs. FactSet Est of $2.07 - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences shares rise as Q3 earnings, revenue beat expectations - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences Reports Third Quarter 2025 Financial Results - PR Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

How big funds are accumulating Neurocrine Biosciences Inc. (NB3) stockPortfolio Gains Summary & Risk Adjusted Buy/Sell Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Peregrine Capital Management LLC - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Is Neurocrine Biosciences Inc. (NB3) stock a buy during volatile marketsMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Neurocrine Biosciences Inc. stock hit analyst price targetsWeekly Gains Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Trend Recap: How rising interest rates impact Neurocrine Biosciences Inc. stockWeekly Risk Summary & Fast Entry and Exit Trade Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

How risky is Neurocrine Biosciences Inc. stock nowJuly 2025 Intraday Action & Fast Gain Stock Tips - newser.com

Oct 27, 2025

뉴로크린 바이오사이언시스 (NBIX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

뉴로크린 바이오사이언시스 주식 (NBIX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
GORMAN KEVIN CHARLES
Director
Aug 07 '25
Sale
126.41
106,322
13,440,281
514,596
$10.36
price up icon 0.88%
drug_manufacturers_specialty_generic RDY
$13.45
price up icon 0.30%
$22.57
price down icon 0.09%
$44.06
price down icon 5.51%
$453.53
price down icon 0.39%
자본화:     |  볼륨(24시간):